Cart
sales@molnova.com
Lorpucitinib
CAS No. 2230282-02-5
Lorpucitinib( —— )
Catalog No. M35614 CAS No. 2230282-02-5
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 543 | In Stock |
|
| 10MG | 867 | In Stock |
|
| 25MG | 1644 | In Stock |
|
| 50MG | 2595 | In Stock |
|
| 100MG | 3506 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLorpucitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
-
DescriptionLorpucitinib is a Gut-Restricted JAK Inhibitor for the research of Inflammatory Bowel Disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230282-02-5
-
Formula Weight408.5
-
Molecular FormulaC22H28N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (612.00 mM; Ultrasonic )
-
SMILESCC(C)(O)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leonard KA, Madge LA, Krawczuk PJ, Wang A, Kreutter KD, Bacani GM, Chai W, Smith RC, Tichenor MS, Harris MC, Malaviya R, Seierstad M, Johnson ME, Venable JD, Kim S, Hirst GC, Mathur AS, Rao TS, Edwards JP, Rizzolio MC, Koudriakova T. Discovery of a Gut-Re?
molnova catalog
related products
-
JKA3 inhibitor 31
JKA3 inhibitor 31 is a highly potent, selective, reversible, covalent JAK3 inhibitor with IC50 of 49 nM.
-
WHI-P131
Janex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3.
-
Axltide
Axltide is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).Peptide sequence (KKSRGDYMTMQIG) is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).
